Comparison of extraction procedures for assessment of matrix effect for selective and reliable determination of atazanavir in human plasma by LC-ESI-MS/MS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 885-886, Issue , 2012, Pages 138-149

  Yadav, Manish ^a,c   Trivedi, Vikas ^a   Upadhyay, Vivek ^a   Shah, Gaurang ^a   Baxi, Girin A ^c   Goswami, Sailendra ^a   Shrivastav, Pranav S ^b  

^a ZYDUS RESEARCH CENTRE   (India)

^b GUJARAT UNIVERSITY   (India)

^c KSKV Kachchh University   (India)

Author keywords

Atazanavir; Extraction procedures; Human plasma; Indinavir; Ion suppression; LC ESI MS MS; Post column infusion

Indexed keywords

ATAZANAVIR; EXTRACTION PROCEDURES; HUMAN PLASMAS; INDINAVIR; ION-SUPPRESSION; LC-ESI-MS/MS; POST-COLUMN;

AMMONIUM COMPOUNDS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; METHANOL;

PLASMA (HUMAN);

AMPRENAVIR; ATAZANAVIR; DARUNAVIR; ETRAVIRINE; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; TIPRANAVIR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PLASMA CONCENTRATION-TIME CURVE; PRECIPITATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN PRECIPITATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ACETONITRILES; CHROMATOGRAPHY, LIQUID; CROSS-OVER STUDIES; DRUG STABILITY; HUMANS; INDINAVIR; MALE; METHANOL; OLIGOPEPTIDES; PYRIDINES; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY;

EID: 84856642596     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.12.031     Document Type: Article

References (55)

1. Schuhmacher J., Zimmer D., Tesche F., Pickard V. Rapid Commun. Mass Spectrom. 2003, 17:1950.
2. Mei H., Hsieh Y., Nardo C., Xu X., Wang S., Ng K., Korfmacher W.A. Rapid Commun. Mass Spectrom. 2003, 17:97.
3. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
4. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., Olah T. J. Am. Soc. Mass Spectrom. 2000, 11:942.
5. Taylor P.J. Clin. Biochem. 2005, 38:328.
6. Matuszewski B.K. J. Chromatogr. B 2006, 830:293.
7. Chambers E., Wagrowski-Diehl D.M., Lu Z., Mazzeo J.R. J. Chromatogr. B 2007, 852:22.
8. Xia Y-Q., Jemal M. Rapid Commun. Mass Spectrom. 2009, 23:2125.
9. Cote C., Bergeron A., Mess J.-N., Furtado M., Garofolo F. Bioanalysis 2009, 1:1243.
10. Eeckhaut A.V., Lanckmans K., Sarre S., Smolders I., Michotte Y. J. Chromatogr. B 2009, 877:2198.
11. Guo X., Lankmayr E. Bioanalysis 2011, 3:349.
12. Bonfiglio R., King R., Olah T., Merkle K. Rapid Commun. Mass Spectrom. 1999, 13:1175.
13. Delaugerre C., Peytavin G., Dominguez S., Marcelin A.G., Duvivier C., Gourlain K., Amellal B., Legrand M., Raffi F., Costagliola D., Katlama C., Calvez V. J. Med. Virol. 2005, 77:345.
14. Breckenridge A. Medicine 2009, 37:374.
15. De Clercq E. Adv. Antiviral Drug Des. 2004, 4:1.
16. Ray J.E., Marriott D., Bloch M.T., McLachlan A.J. Br. J. Clin. Pharmacol. 2005, 60:291.
17. Bristol-Myers Squibb Company, Reyataz®, Package Insert. 2006 (last assessed 20.08.11). http://packageinserts.bms.com/pi/pi.reyataz.pdf.
18. Jemal M., Rao S., Gatz M., Whigan D. J. Chromatogr. B 2003, 795:273.
19. Colombo S., Guignard N., Marzolini C., Telenti A., Biollaz J., Decosterd L.A. J. Chromatogr. B 2004, 810:25.
20. Cateau E., Tournier N., Dupuis A., Moal G.L., Venisse N. J. Pharm. Biomed. Anal. 2005, 39:791.
21. Sparidans R.W., Dost F., Crommentuyn K.M.L., Huitema A.D.R., Schellens J.H.M., Beijnen J.H. Biomed. Chromatogr. 2006, 20:72.
22. Loregian A., Pagni S., Ballarin E., Sinigalia E., Parisi S.G., Palu G. J. Pharm. Biomed. Anal. 2006, 42:500.
23. Muller A.C., Kanfer I. J. Pharm. Biomed. Anal. 2010, 53:113.
24. Schuster A., Burzawa S., Jemal M., Loizillon E., Couerbe P., Whigan D. J. Chromatogr. B 2003, 788:377.
25. Crommentuyn K.M.L., Rosing H., Hillebrand M.J.X., Huitema A.D.R., Beijnen J.H. J. Chromatogr. B 2004, 804:359.
26. Dailly E., Raffi F., Jolliet P. J. Chromatogr. B 2004, 813:353.
27. Poirier J.M., Robidou P., Jaillon P. Ther. Drug Monit. 2005, 27:186.
28. Colombo S., Beguin A., Telenti A., Biollaz J., Buclin T., Rochat B., Decosterd L.A. J. Chromatogr. B 2005, 819:259.
29. Takahashi M., Yoshida M., Oki T., Okumura N., Suzuki T., Kaneda T. Biol. Pharm. Bull. 2005, 28:1286.
30. Dickinson L., Robinson L., Tjia J., Khoo S., Back D. J. Chromatogr. B 2005, 829:82.
31. Crommentuyn K.M.L., Huitema A.D.R., Beijnen J.H. J. Pharm. Biomed. Anal. 2005, 38:139.
32. Notari S., Bocedi A., Ippolito G., Narciso P., Pucillo L.P., Tossini G., Donnorso R.P., Gasparrini F., Ascenzi P. J. Chromatogr. B 2006, 831:258.
33. Rezk N.L., Crutchley R.D., Yeh R.F., Kashuba A.D.M. Ther. Drug Monit. 2006, 28:517.
34. Xu R.N., Fan L., Kim G.E., El-Shourbagy T.A. J. Pharm. Biomed. Anal. 2006, 40:728.
35. Verbesselt R., Wijngaerden E.V., de Hoon J. J. Chromatogr. B 2007, 845:51.
36. Gu J., Soldin S.J. Clin. Chim. Acta 2007, 378:222.
37. Weller D.R., Brundage R.C., Balfour H.H., Vezina H.E. J. Chromatogr. B 2007, 848:369.
38. D'Avolio A., Siccardi M., Sciandra M., Baietto L., Bonora S., Trentini L., Di Perri G. J. Chromatogr. B 2007, 859:234.
39. Choi S.O., Rezk N.L., Kashuba A.D.M. J. Pharm. Biomed. Anal. 2007, 43:1562.
40. ter Heine R., Alderden C.G., Rosing H., Hillebrand M.J., van Gorp E.C., Huitema A.D., Beijnen J.H. Rapid Commun. Mass Spectrom. 2007, 21:2505.
41. Robledo V.R., Smyth W.F. Anal. Chim. Acta 2008, 623:221.
42. ter Heine R., Rosing H., van Gorp E.C.M., Mulder J.W., van der Steeg W.A., Beijnen J.H., Huitema A.D.R. J. Chromatogr. B 2008, 867:205.
43. D'Avolio A., Baietto L., Siccardi M., Sciandra M., Simiele M., Oddone V., Bonora S., Di Perri G. Ther. Drug Monit. 2008, 30:662.
44. Quaranta S., Woloch C., Paccou A., Giocanti M., Solas C., Lacarelle B. Ther. Drug Monit. 2009, 31:695.
45. Elens L., Veriter S., Di Fazio V., Vanbinst R., Boesmans D., Wallem-Acq P., Haufroid V. Clin. Chem. 2009, 55:170.
46. Martin J., Deslandes G., Dailly E., Renaud C., Reliquet V., Raffi F., Jolliet P. J. Chromatogr. B 2009, 877:3072.
47. ter Heine R., Davids M., Rosing H., van Gorp E.C.M., Mulder J.W., van der Heide Y.T., Beijnen J.H., Huitema A.D.R. J. Chromatogr. B 2009, 877:575.
48. Elens L., Veriter S., Yombi J.C., Fazio V.D., Vanbinst R., Lison D., Wallemacq P., Vandercam B., Haufroid V. J. Chromatogr. B 2009, 877:1805.
49. D'Avolio A., Simiele M., Siccardi M., Baietto L., Sciandra M., Bonora S., Di Perri G. J. Pharm. Biomed. Anal. 2010, 52:774.
50. Else L., Watson V., Tjia J., Hughes A., Siccardi M., Khoo S., Back D. J. Chromatogr. B 2010, 878:1455.
51. D'Avolio A., Simiele M., Siccardi M., Baietto L., Sciandra M., Oddone V., Stefani F.R., Agati S., Cusato J., Bonora S., Di Perri G. J. Pharm. Biomed. Anal. 2011, 54:779.
52. Guidance for Industry, Bionanlytical Method Validation, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001.
53. Guidance for Industry: ICH E6 Good Clinical Practice, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), April 1996.
54. Rocci M.L., Devanarayan V., Haughey D.B., Jardieu P. AAPS J. 2007, 9:E336.
55. Martin D.E., Galbraith H., Schettler J., Ellis C., Doto J. Clin. Ther. 2008, 30:1794.